Development of otology specific outcome measure:Ear Outcome Survey-16 (EOS-16)
Juha T.Laakso1
Juha Silvola2
Timo Hirvonen1
Samuli Suutarla3
Ilkka Kivek?s4
Riitta Saarinen1
Lotta Haavisto5
Jaakko Laitakari6
Antti A.Aarnisalo1
Aarno Dietz7
Jussi Jero5
Maija Hyt?nen1
Saku T.Sinkkonen1
1.Department of Otorhinolaryngology-Head and Neck Surgery,Head and Neck Center,Helsinki University Hospital and University of Helsinki,Helsinki,Finland2.Department of Ear,Nose,and Throat-Division of Surgery,Akershus University Hospital,L?renskog,Norway3.Department of Otorhinolaryngology-Head and Neck Surgery,Head and Neck Center,Helsinki University Hospital and University of Helsinki,Helsinki,Finland;Department of Otorhinolaryngology,Kymenlaakso Central Hospital,Kotka,Finland4.Department of Otorhinolaryngology-Head and Neck Surgery,Tampere University Hospital and Tampere University,Tampere,Finland5.Department of Otorhinolaryngology-Head and Neck Surgery,Turku University Hospital and University of Turku,Turku,Finland6.Department of Otorhinolaryngology-Head and Neck Surgery,Oulu University Hospital and PEDEGO Research Unit,University of Oulu and Medical Research Center Oulu,Finland7.Department of Otorhinolaryngology-Head and Neck Surgery,Kuopio University Hospital and University of Kuopio,Kuopio,Finland
摘要：Purpose: An important outcome measure of patient care is the impact on the patient's health-related quality of life (HRQoL). Current ear-specific HRQoL instruments are designed for one diagnosis and emphasize different subdivisions such as symptoms, hearing problems, psychosocial impact, and the need for care. The optimal length of the recall period has not been studied. For these reasons, a new survey is needed that would cover most chronic ear diseases.Methods: A preliminary 24-item survey (EOS-24) was created. Untreated adult patients (included n=186) with one of seven different chronic otologic conditions from all university hospitals in Finland were recruited to respond to EOS-24 and the 15D general HRQoL instrument. The recruiting otologists evaluated the severity of the disease and the disability caused by it. A control group was recruited. Based on the patients' responses in different diagnosis groups, the items were reduced according to pre-defined criteria. The resulting survey was validated using a thorough statistical analysis. Results: The relevance and necessity of the original 24 items were thoroughly investigated, leading to the exclusion of 8 items and the modification of 1. The remaining 16 items were well-balanced between subdivisions and were useful in all seven diagnosis groups, thus constituting the final instrument, EOS-16. The most suitable recall period was three months. Conclusions: EOS-16 has been created according to the HRQoL survey guidelines with a versatile nationwide patient population. The survey has been validated and can be used for a wide range of chronic ear diseases as a HRQoL instrument.
机标关键词：
论文发表日期：2021-09-30
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：8( 150-157 )
英文信息